Terbinafine (Lamisil) and Renal Function
Yes, terbinafine can affect renal function and is contraindicated in patients with renal impairment according to the British Association of Dermatologists' guidelines. 1
Renal Considerations with Terbinafine
- Terbinafine is primarily cleared by the kidneys, and its clearance is decreased in patients with severe kidney disease 2
- The British Association of Dermatologists explicitly lists renal impairment as a contraindication for terbinafine use 1
- Patients with reduced renal function may experience drug accumulation, potentially leading to increased risk of adverse effects 3
Documented Renal Effects
- Case reports have documented severe adverse renal outcomes with terbinafine use, including:
Monitoring Recommendations
- Baseline assessment of renal function should be performed before initiating terbinafine therapy 2
- In patients with pre-existing renal disease, alternative antifungal medications should be considered 1
- Fluconazole is also contraindicated in renal impairment, but itraconazole may be a better alternative in patients with renal issues but normal hepatic function 1
Pharmacokinetic Considerations
- Unlike some medications where dose adjustments can compensate for reduced renal function, terbinafine is specifically contraindicated rather than recommended for adjusted dosing 1
- The drug's long half-life and persistence in nail tissue for up to 30 weeks after treatment completion may contribute to prolonged exposure in patients with impaired renal clearance 6
Clinical Implications
- For patients requiring antifungal therapy who have renal impairment, topical treatments like amorolfine or ciclopirox may be safer alternatives 1
- Patients on terbinafine should be monitored for signs of renal dysfunction, including changes in urination patterns, edema, or unexplained fatigue 4, 5
- If renal dysfunction develops during terbinafine treatment, the medication should be discontinued immediately 4
Terbinafine remains a first-line treatment for dermatophyte onychomycosis in patients with normal renal function, but its use requires careful consideration of renal status before initiation 1, 6.